Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 2, Issue , 2016, Pages 1-11

  Knopman, David S ^a   Gottesman, Rebecca F ^b   Sharrett, Albert Richey ^c   Wruck, Lisa M ^d   Windham, Beverly Gwen ^e   Coker, Laura ^f   Schneider, Andrea L C ^c   Hengrui, Sun ^d   Alonso, Alvaro ^g   Coresh, Josef ^c   Albert, Marilyn S ^b   Mosley, Thomas H ^e  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Dementia; Epidemiology; Mild cognitive impairment; Prevalence

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; SURVIVOR; TELEPHONE INTERVIEW; VALIDATION STUDY;

EID: 84955134966     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2015.12.002     Document Type: Article

References (46)

1. Hy L.X., Keller D.M. Prevalence of AD among whites: A summary by levels of severity. Neurology 2000, 55:198-204.
2. Fillenbaum G.G., Peterson B., Welsh-Bohmer K.A., Kukull W.A., Heyman A. Progression of Alzheimer's disease in black and white patients: The CERAD experience, part XVI. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998, 51:154-158.
3. Hendrie H.C., Osuntokun B.O., Hall K.S., Ogunniyi A.O., Hui S.L., Unverzagt F.W., et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995, 152:1485-1492.
4. Chene G., Beiser A., Au R., Preis S.R., Wolf P.A., Dufouil C., et al. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement 2015, 11:310-320.
5. White L., Petrovitch H., Ross G.W., Masaki K.H., Abbott R.D., Teng E.L., et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 1996, 276:955-960.
6. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol 1989, 129:687-702. ARIC Investigators.
7. Cerhan J.R., Folsom A.R., Mortimer J.A., Shahar E., Knopman D.S., McGovern P.G., et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) study investigators. Gerontology 1998, 44:95-105.
8. Knopman D., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56:42-48.
9. Mosley T.H., Knopman D.S., Catellier D.J., Bryan N., Hutchinson R.G., Grothues C.A., et al. Cerebral MRI findings and cognitive functioning: The Atherosclerosis Risk in Communities study. Neurology 2005, 64:2056-2062.
10. Kohout F.J., Berkman L.F., Evans D.A., Cornoni-Huntley J. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 1993, 5:179-193.
11. Schneider A.L., Sharrett A.R., Gottesman R.F., Coresh J., Coker L., Wruck L., et al. Normative data for 8 neuropsychological tests in older blacks and whites from the Atherosclerosis Risk in Communities (ARIC) study. Alzheimer Dis Assoc Disord 2015, 29:32-44.
12. Knopman D.S., Mosley T.H., Catellier D.J., Coker L.H. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement 2009, 5:207-214.
13. Gottesman R.F., Rawlings A.M., Sharrett A.R., Albert M., Alonso A., Bandeen-Roche K., et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: The ARIC neurocognitive study. Am J Epidemiol 2014, 179:956-966.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
15. Weintraub S., Salmon D., Mercaldo N., Ferris S., Graff-Radford N.R., Chui H., et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009, 23:91-101.
16. Knopman D.S., Griswold M.E., Lirette S.T., Gottesman R.F., Kantarci K., Sharrett A.R., et al. Vascular imaging abnormalities and cognition: Mediation by cortical volume in nondemented individuals: Atherosclerosis Risk in Communities-Neurocognitive study. Stroke 2015, 46:433-440.
17. Goldstein L.B., Bertels C., Davis J.N. Interrater reliability of the NIH stroke scale. Arch Neurol 1989, 46:660-662.
18. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease 1987, 153-163. Committee. UD, MacMillan Healthcare Information, Florham Park. S. Fahn (Ed.).
19. Morris J.C. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 1993, 43:2412-2414.
20. Pfeffer R.I., Kurosaki T.T., Harrah C.H., Chance J.M., Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982, 37:323-329.
21. Kaufer D.I., Cummings J.L., Ketchel P., Smith V., MacMillan A., Shelley T., et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000, 12:233-239.
22. Rosen W.G., Terry R.D., Fuld P.A., Katzman R., Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980, 7:486-488.
23. Welsh K.A., Breitner J.C., Magruder-Habib K.M. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry, Neuropsychology, Behavioral Neurology 1993, 6:103-110.
24. Knopman D.S., Roberts R.O., Geda Y.E., Pankratz V.S., Christianson T.J., Petersen R.C., et al. Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia. Neuroepidemiology 2010, 34:34-42.
25. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R.J., Kawas C.H., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:263-269.
26. Albert M., DeKosky S.T., Dickson D., Dubois B., Feldman H., Fox N.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:270-279.
27. DSM-5: Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, American Psychiatric Association, Washington, DC. 5th ed.
28. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
29. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
30. Ferman T.J., Boeve B.F., Smith G.E., Lin S.C., Silber M.H., Pedraza O., et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 2011, 77:875-882.
31. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54(11 Suppl 5):S4-S9.
32. Petersen R.C., Roberts R.O., Knopman D.S., Geda Y.E., Cha R.C., Pankratz V.S., et al. Prevalence of mild cognitive impairment is higher in men than in women. The Mayo Clinic Study of Aging. Neurology 2010, 75:889-897.
33. Plassman B.L., Langa K.M., Fisher G.G., Heeringa S.G., Weir D.R., Ofstedal M.B., et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 2008, 148:427-434.
34. Lopez O.L., Jagust W.J., DeKosky S.T., Becker J.T., Fitzpatrick A., Dulberg C., et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: Part 1. Arch Neurol 2003, 60:1385-1389.
35. Knopman D.S., Roberts R.O., Pankratz V.S., Cha R.H., Rocca W.A., Mielke M.M., et al. Incidence of dementia among participants and nonparticipants in a Longitudinal Study of Cognitive Aging. Am J Epidemiol 2014, 180:414-423.
36. Fillenbaum G.G., Heyman A., Huber M.S., Woodbury M.A., Leiss J., Schmader K.E., et al. The prevalence and 3-year incidence of dementia in older black and white community residents. J Clin Epidemiol 1998, 51:587-595.
37. Katz M.J., Lipton R.B., Hall C.B., Zimmerman M.E., Sanders A.E., Verghese J., et al. Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: A report from the Einstein Aging Study. Alzheimer Dis Assoc Disord 2012, 26:335-343.
38. Plassman B.L., Langa K.M., Fisher G.G., Heeringa S.G., Weir D.R., Ofstedal M.B., et al. Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 2007, 29:125-132.
39. Hall K.S., Gao S., Baiyewu O., Lane K.A., Gureje O., Shen J., et al. Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001. Alzheimers Dement 2009, 5:227-233.
40. Fitzpatrick A.L., Kuller L.H., Ives D.G., Lopez O.L., Jagust W., Breitner J.C., et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004, 52:195-204.
41. Canadian study of health and aging: Study methods and prevalence of dementia. CMAJ 1994, 150:899-913. Canadian Study of Health and Aging Working Group.
42. Knopman D.S., Petersen R.C., Rocca W.A., Larson E.B., Ganguli M. Passive case-finding for Alzheimer's disease and dementia in two U.S. communities. Alzheimers Dement 2011, 7:53-60.
43. Gold G., Bouras C., Canuto A., Bergallo M.F., Herrmann F.R., Hof P.R., et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002, 159:82-87.
44. Yu L., Boyle P.A., Leurgans S., Schneider J.A., Kryscio R.J., Wilson R.S., et al. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging 2015, 36:2225-2231.
45. White L. Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: A summary report from the Honolulu-Asia aging study. J Alzheimers Dis 2009, 18:713-725.
46. Sonnen J.A., Larson E.B., Crane P.K., Haneuse S., Li G., Schellenberg G.D., et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007, 62:406-413.